UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007510 |
|---|---|
| Receipt number | R000008864 |
| Scientific Title | A phase 2 study of weekly Nab-Paclitaxel followed by FEC (Fluorouracil, Epirubicin, Cyclophosphamide) as primary therapy for operable breast cancer |
| Date of disclosure of the study information | 2012/03/16 |
| Last modified on | 2012/12/26 15:18:53 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/03/15 00:32:32 | ||
| 2 | Update | 2012/12/26 15:18:53 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
